How Big Is the Injectable Drug Market | Trends & Insights 2031

Q: What is the size of the injectable drug market?

The injectable drug market is forecasted to reach approximately USD 964.8 billion by 2031, supported by demand in oncology, diabetes, and infectious disease management.

Q: Who are the key players in the injectable drug market?

Leading companies in the injectable drug market include Pfizer, Sanofi, Novartis, and Amgen, all playing a major role in biologics and vaccine development.

Q: What factors are driving the injectable drug market globally?

The injectable drug market is driven by chronic disease prevalence, biologics expansion, and the need for rapid and effective drug administration.

Q: How competitive is the injectable drug market?

It is a highly competitive market with pharmaceutical giants investing in R&D, biosimilars, and strategic partnerships to expand injectable drug portfolios.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA6684

Publication Date: Jul 2025

How Big Is the Injectable Drug Market?

According to 6Wresearch internal database and industry insights, the injectable drug market was valued at USD 557.2 billion in 2024 and is projected to reach USD 964.8 billion by 2031, expanding at a CAGR of 8.1%.

There is an increasing demand for biologics, monoclonal antibodies and vaccines, which is helping expand the use of injectables. Injectables work quickly and are an ideal way to deliver the poorly absorbed drugs typically seen in oncology, autoimmune, and infectious disease practices.

Growth Factors of the Injectable Drug Market

The prevalence of chronic and infectious diseases such as cancer, diabetes, and HIV is rising globally.
There is increased approvals and commercialization of biologics and biosimilars products that require parenteral delivery.
There will be a growing preference for fast-acting therapies, especially in emergency care.
Demand for vaccines has surged globally post-COVID-19 and immunization programs are advancing globally.
Science of formulation is advancing, enhancing the stability and delivery of injectable drugs.

Injectable Drug Market Trends

The injectable drug market is witnessing strong demand for long-acting formulations, depot injections, and extended-release therapeutics. The oncology and diabetes treatment spaces are major drivers, with increasing development of subcutaneous and intramuscular injections. Innovation in lyophilized injectable drug technology is supporting shelf life improvements. Additionally, partnerships between pharma firms and contract manufacturing organizations (CMOs) are strengthening production and scalability.

Emerging Developments in the Injectable Drug Market

The industry is moving to a patient-centred delivery format with autoinjectors, wearable devices, and pen injectors. Development of nanoparticle therapeutics and liposomal drug delivery is happening to enhance absorption and reduce toxicity. The regulatory pathways for complex injectable generics are changing and more streamlined for complex injectables, shortening time to market. There is investment into manufacturing capacity, specifically in the Asia-Pacific region, as well as changing global supply chains.